Schedule
Schedule as of September 26, 2025, subject to change
7:15 – 7:55 am: Registration & Continental Breakfast
7:55 am: Welcome – Adam Boruchov, MD and Amer Zeidan, MBBS, MHS
8:00 – 8:35 am: What’s New in Upfront Treatment of DLBCL
Gilles Salles, MD – Memorial Sloan Kettering Cancer Center
8:35 – 9:10 am: Treatment of Relapsed Refractory DLBCL
Philippe Armand, MD, PhD – Dana Farber Cancer Institute
9:10 – 9:45 am: Sequencing Considerations for BiTE and CAR-T Therapy for Lymphoma
David L. Porter, MD – University of Pennsylvania Health System
BREAK
10:00 – 10:35 am: Al-Amyloidosis: What’s Next After First-line Therapy
Morie A. Gertz, MD, MACP – Mayo Clinic
10:35 – 11:10 am: TE-NDMM: Upfront Quad Therapy/MRD Negativity Can Forgo Transplant
Robert Z. Orlowski, MD, PhD – MD Anderson Cancer Center
11:10 – 11:45 am: Sequence of Immunotherapies – BiTE/CAR-T
Nikhil C. Munshi, MD – Dana Farber Cancer Institute
12:00 – 1:00 pm: General Attendee Lunch & Faculty/Fellows Gathering
1:00 – 1:35 pm: How I Manage MPNs in 2025
Prithviraj Bose, MD – MD Anderson Cancer Center
1:35 – 2:10 pm: AML
Selina Luger, MD, FRCPC – University of Pennsylvania Health System
2:10 – 2:45 pm: MDS
Amer Zeidan, MBBS, MHS – Yale Hospital, Smilow Cancer Center
BREAK
3:00 – 3:35 pm: How I Treat Arterial Thrombosis
Stephan Moll, MD – University of North Carolina School of Medicine
3:35 – 4:10 pm: How I Treat Aplastic Anemia
Neal S. Young, MD – National Institutes of Health
4:10 – 4:45 pm: Panel Q&A – Faculty
In planning partnership with
